New study reveals more than 1/3 of early-phase clinical trial participants reported Financial Toxicity – ACS Journal Cancer
ACS Journal Cancer shared a post on X about a recent paper by Sienna Durbin et al. published in Cancer.
“New study led by Sienna Durbin et al reveals more than 1/3 of early-phase clinical trial participants reported Financial Toxicity. Patients with financial toxicity reported lower QOL and acceptance, and increased self blame.”
Anh Lam, Resident at OU Health, shared this post, adding;
“So excited for Sienna Durbin et al for publishing this work and very grateful to work with her and be a part of this phenomenal team!!”
“Financial toxicity in early-phase cancer clinical trial participants”
Authors: Sienna Durbin, Debra Lundquist, Andrea Pelletier, Dejan Juric, Ryan Nipp et al.
Sienna Marie Durbin, M.D., is a Clinical Fellow in Medicine at Dana-Farber Cancer Institute, specializing in inpatient oncology. She is involved in the Hematology/Oncology department, focusing on providing comprehensive care for patients undergoing treatment for various types of cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023